載入...
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
The KRAS gene is frequently mutated in multiple cancer types, but it fell off the drug discovery radar for many years because of its inherent “undruggable” structure and undefined biological properties. As reported in the paper entitled “Suppression of KRas-mutant cancer through the combined inhibit...
Na minha lista:
| 發表在: | Chin J Cancer |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086049/ https://ncbi.nlm.nih.gov/pubmed/27793187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0154-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|